Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression

Journal of Virology

Volumn 77, Issue 8, 2003, Pages 4658-4669

  Kopecky, Sarah A ^a   Lyles, Douglas S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; APOPTOSIS INDUCING FACTOR; APOPTOSIS INHIBITOR; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; DACTINOMYCIN; MATRIX PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN BHK; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS MUTANT;

ANIMALS; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; CELL LINE; CRICETINAE; DACTINOMYCIN; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL MATRIX PROTEINS;

EID: 0037383430     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.8.4658-4669.2003     Document Type: Article

References (42)

1. Ahmed, M., and D. S. Lyles. 1997. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression. Virology 237:378-388.
2. Ahmed, M., and D. S. Lyles. 1998. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III, J. Virol. 72:8413-8419.
3. a.Ahmed, M., M. O. McKenzie, S. Puckett, M. Hojnacki, L. Poliquin, and D. S. Lyles. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Virol. 77:4646-4657.
4. Albrecht, H., J. Tschopp, and C. V. Jongeneel. 1994. Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF. FEBS Lett. 351:45-48.
5. Antonsson, B., and J. C. Martinou. 2000. The Bcl-2 protein family. Exp. Cell Res. 256:50-57.
6. Balachandran, S., C. N. Kim, W. C. Yeh, T. W. Mak, K. Bhalla, and G. N. Barber. 1998. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17:6888-6902.
7. Balachandran, S., M. Porosnicu, and G. N. Barber. 2001. Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis. J. Virol. 75:3474-3479.
8. Balachandran, S., P. C. Roberts, T. Kipperman, K. N. Bhalla, R. W. Compans, D. R. Archer, and G. N. Barber. 2000. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74:1513-1523.
9. Black, B. L., G. Brewer, and D. S. Lyles. 1994. Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo. J. Virol. 68:555-560.
10. Black, B. L., and D. S. Lyles. 1992. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 66:4058-4064.
11. Black, B. L., R. B. Rhodes, M. McKenzie, and D. S. Lyles. 1993. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J. Virol. 67:4814-4821.
12. Bolt, G., K. Berg, and M. Blixenkrone-Moller. 2002. Measles virus-induced modulation of host-cell gene expression. J. Gen. Virol. 83:1157-1165.
13. Collins, J. A., C. A. Schandi, K. K. Young, J. Vesely, and M. C. Willingham. 1997. Major DNA fragmentation is a late event in apoptosis. J. Histochem. Cytochem. 45:923-934.
14. Der, S. D., Y. L. Yang, C. Weissmann, and B. R. Williams. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:3279-3283.
15. Desforges, M., G. Despars, S. Berard, M. Gosselin, M. O. McKenzie, D. S. Lyles, P. J. Talbot, and L. Poliquin. 2002. Matrix protein mutations contribute to inefficient induction of apoptosis leading to persistent infection of human neural cells by vesicular stomatitis virus. Virology 295:63-73.
16. Dunigan, D. D., S. Baird, and J. Lucas-Lenard. 1986. Lack of correlation between the accumulation of plus-strand leader RNA and the inhibition of protein and RNA synthesis in vesicular stomatitis virus infected mouse L cells. Virology 150:231-246.
17. Ferran, M. C., and J. M. Lucas-Lenard. 1997. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J. Virol. 71:371-377.
18. Florkiewicz, R. Z., A. Smith, J. E. Bergmann, and J. K. Rose. 1983. Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J. Cell Biol. 97:1381-1388.
19. Fulda, S., E. Meyer, and K. M. Debatin. 2002. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21:2283-2294.
20. Geiss, G., G. Jin, J. Guo, R. Bumgarner, M. G. Katze, and G. C. Sen. 2001, A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. 276:30178-30182.
21. Grinnell, B. W., and R. R. Wagner. 1983. Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA. J. Virol. 48:88-101.
22. Her, L. S., E. Lund, and J. E. Dahlberg. 1997. Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276:1845-1848.
23. Jaattela, M., M. Benedict, M. Tewari, J. A. Shayman, and V. M. Dixit. 1995. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10:2297-2305.
24. Joo, C. H., Y. K. Kim, H. Lee, H. Hong, S. Y. Yoon, and D. Kim. 2002. Coxsackievirus B4-induced neuronal apoptosis in rat cortical cultures. Neurosci. Lett. 326:175-178.
25. Kopecky, S. A., M. C. Willingham, and D. S. Lyles, 2001. Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J. Virol. 75:12169-12181.
26. Koyama, A. H. 1995. Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus. Virus Res. 37:285-290.
27. Laub, O., E. B. Jakobovits, and Y. Aloni, 1980. 5,6-Dichloro-1-B-ribofuranosylbenzimidazole enhances premature termination of late transcription of simian virus 40 DNA. Proc. Natl. Acad. Sci. USA 77:3297-3301.
28. Lee, S. B., and M. Esteban. 1994. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199:491-496.
29. Lyles, D. S., and M. O. McKenzie. 1997. Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function. Virology 299:77-89.
30. McGowan, J. J., S. U. Emerson, and R. R. Wagner. 1982. The plus-strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus and SV40 genes in a soluble whole-cell extract. Cell 28:325-333.
31. Namgung, U., and Z. Xia. 2001. Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol. Appl. Pharmacol. 174:130-138.
32. Paik, S.-Y., A. C. Banerjea, G. G. Harmison, C.-J. Chen, and M. Schubert. 1995. Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J. Virol. 69:3529-3537.
33. Petersen, J. M., L.-S. Her, V. Varvel, E. Lund, and J. E. Dahlberg. 2000. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol. Cell. Biol. 20:8590-8601.
34. Poirot, M. K., W. M. Schnitzlein, and M. E. Reichmann. 1985. The requirement of protein synthesis for VSV inhibition of host cell RNA synthesis. Virology 140:91-101.
35. Re, G. G., D. J. Hazen-Martin, R. El Bahtimi, N. A. Brownlee, M. C. Willingham, and A. J. Garvin. 1999. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases. Int. J. Cancer 84:192-200.
36. Seol, D. W., J. Li, M. H. Seol, S. Y. Park, R. V. Talanian, and T. R, Billiar. 2001. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis. Cancer Res. 61:1138-1143.
37. Thomis, D. C., and C. E. Samuel. 1995. Mechanism of interferon action: characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase. J. Virol. 69:5195-5198.
38. von Kobbe, C., J. M. van Deursen, J. P. Rodrigues, D. Sitterlin, A. Bachi, X. Wu, M. Wilm, M. Carmo-Fonseca, and E. Izaurralde. 2000. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin nup98. Mol. Cell 6:1243-1252.
39. Wieder, T., F. Essmann, A. Prokop, K. Schmelz, K. Schulze-Osthoff, R. Beyaert, B. Dorken, and P. T. Daniel, 2001. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97:1378-1387.
40. Yuan, H., S. Puckett, and D. S. Lyles. 2001. Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits. J. Virol. 75:4453-4458.
41. Yuan, H., B. K. Yoza, and D. S. Lyles. 1998. Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID. Virology 251:383-392.
42. Zandomeni, R., M. C. Zandomeni, D. Shugar, and R. Weinmann. 1986. Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. J. Biol. Chem. 261:3414-3419.